This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2011:50:109-33.

doi: 10.1016/B978-0-12-381290-2.00003-3.

Progress in the development of small molecule therapeutics targeting Th17 cell function for the treatment of immune-inflammatory diseases

Stephen Shuttleworth¹, Paul Townsend, Franck Silva, Alexander Cecil, Thomas Hill, Cyrille Tomassi, Helen Rogers, Rebecca Harrison

Affiliations

PMID: 21315929
DOI: 10.1016/B978-0-12-381290-2.00003-3

Progress in the development of small molecule therapeutics targeting Th17 cell function for the treatment of immune-inflammatory diseases

Stephen Shuttleworth et al. Prog Med Chem. 2011.

. 2011:50:109-33.

doi: 10.1016/B978-0-12-381290-2.00003-3.

Authors

Stephen Shuttleworth¹, Paul Townsend, Franck Silva, Alexander Cecil, Thomas Hill, Cyrille Tomassi, Helen Rogers, Rebecca Harrison

Affiliation

¹ Karus Therapeutics Ltd., 2 Venture Road, Southampton Science Park, Southampton, SO16 7NP, UK.

PMID: 21315929
DOI: 10.1016/B978-0-12-381290-2.00003-3

No abstract available

PubMed Disclaimer

Similar articles

Immunopathology alters Th17 cell glucocorticoid sensitivity.
Banuelos J, Cao Y, Shin SC, Lu NZ. Banuelos J, et al. Allergy. 2017 Mar;72(3):331-341. doi: 10.1111/all.13051. Epub 2016 Oct 13. Allergy. 2017. PMID: 27646878 Free PMC article. Review.
Inhibiting RORγt/Th17 axis for autoimmune disorders.
Isono F, Fujita-Sato S, Ito S. Isono F, et al. Drug Discov Today. 2014 Aug;19(8):1205-11. doi: 10.1016/j.drudis.2014.04.012. Epub 2014 Apr 30. Drug Discov Today. 2014. PMID: 24792721 Review.
Anti-inflammatory drug development: Broad or specific chemokine receptor antagonists?
Russo RC, Garcia CC, Teixeira MM. Russo RC, et al. Curr Opin Drug Discov Devel. 2010 Jul;13(4):414-27. Curr Opin Drug Discov Devel. 2010. PMID: 20597027 Review.
The emerging role of CXC chemokines and their receptors in cancer.
Vinader V, Afarinkia K. Vinader V, et al. Future Med Chem. 2012 May;4(7):853-67. doi: 10.4155/fmc.12.48. Future Med Chem. 2012. PMID: 22571611 Review.
Cyclooxygenase 2 controversy: thoughts on the process of discovery, development, and assessment of benefit and risk of therapies for chronic immunoinflammatory diseases of uncertain autoimmune etiology.
Furst DE, Khanna D, Paulus HE. Furst DE, et al. Arthritis Rheum. 2006 Oct 15;55(5):683-6. doi: 10.1002/art.22240. Arthritis Rheum. 2006. PMID: 17013849 No abstract available.

See all similar articles

Cited by

Proinflammatory Cytokines (IL-1, -6, -8, -15, -17, -18, -23, TNF-α) Single Nucleotide Polymorphisms in Rheumatoid Arthritis-A Literature Review.
Koper-Lenkiewicz OM, Sutkowska K, Wawrusiewicz-Kurylonek N, Kowalewska E, Matowicka-Karna J. Koper-Lenkiewicz OM, et al. Int J Mol Sci. 2022 Feb 14;23(4):2106. doi: 10.3390/ijms23042106. Int J Mol Sci. 2022. PMID: 35216226 Free PMC article. Review.
Gut-Induced Inflammation during Development May Compromise the Blood-Brain Barrier and Predispose to Autism Spectrum Disorder.
Eshraghi RS, Davies C, Iyengar R, Perez L, Mittal R, Eshraghi AA. Eshraghi RS, et al. J Clin Med. 2020 Dec 24;10(1):27. doi: 10.3390/jcm10010027. J Clin Med. 2020. PMID: 33374296 Free PMC article. Review.
Progress in the preclinical discovery and clinical development of class I and dual class I/IV phosphoinositide 3-kinase (PI3K) inhibitors.
Shuttleworth SJ, Silva FA, Cecil AR, Tomassi CD, Hill TJ, Raynaud FI, Clarke PA, Workman P. Shuttleworth SJ, et al. Curr Med Chem. 2011;18(18):2686-714. doi: 10.2174/092986711796011229. Curr Med Chem. 2011. PMID: 21649578 Free PMC article. Review.
The role of IL-22 in cancer.
Hunzeker ZE, Zhao L, Kim AM, Parker JM, Zhu Z, Xiao H, Bai Q, Wakefield MR, Fang Y. Hunzeker ZE, et al. Med Oncol. 2024 Sep 5;41(10):240. doi: 10.1007/s12032-024-02481-8. Med Oncol. 2024. PMID: 39231878 Review.
Plant-Derived Terpenoids: A Promising Tool in the Fight against Melanoma.
Kłos P, Chlubek D. Kłos P, et al. Cancers (Basel). 2022 Jan 20;14(3):502. doi: 10.3390/cancers14030502. Cancers (Basel). 2022. PMID: 35158770 Free PMC article. Review.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information